Rep. David Taylor Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative David Taylor (R-Ohio) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on June 02nd, the Representative disclosed that they had sold between $15,001 and $50,000 in UnitedHealth Group stock on May 14th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SARDINIA READY MIX 401(K) – DAVE” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 5/14/2025.
• Sold $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 5/14/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 5/13/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 5/12/2025.
• Purchased $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 5/12/2025.
• Purchased $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 3/27/2025.
• Purchased $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 3/10/2025.
• Purchased $1,001 – $15,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 3/10/2025.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $301.43 on Wednesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $273.44 billion, a PE ratio of 19.45, a PEG ratio of 1.37 and a beta of 0.56. The stock’s 50 day moving average price is $422.31 and its 200-day moving average price is $489.42. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company earned $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director John H. Noseworthy bought 300 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the acquisition, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. The trade was a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last ninety days. 0.33% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently modified their holdings of the company. Waycross Partners LLC lifted its position in UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after purchasing an additional 658 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $515,000. Full Sail Capital LLC lifted its position in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock valued at $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at $39,413,000. Finally, Silvercrest Asset Management Group LLC raised its holdings in UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after acquiring an additional 12,550 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. Bank of America cut UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their target price for the company from $560.00 to $350.00 in a research note on Wednesday, May 14th. Wolfe Research cut their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a research report on Tuesday, May 20th. Barclays dropped their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a report on Monday. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, KeyCorp decreased their target price on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating for the company in a research report on Monday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $428.43.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.